Who
David Polinsky
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Rafael Holdings; Director, Ernexa Therapeutics; Director, Innovative Food Holdings.
In numbers
- Trades disclosed
- 41
- Buys
- 1
- Sells
- 0
- Bought
- $125K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 28 Mar 2018
- Last trade
- 21 Sep 2026
- Last filed
- 23 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Sep 2026filed 23 Sep 2026 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $4,1052,027 at $2.03 | filing |
| 21 Sep 2026filed 23 Sep 2026 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $4,1152,027 at $2.03 | filing |
| 31 Aug 2026filed 1 Sep 2026 | ERNA Ernexa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,083 at $0.00 | filing |
| 31 Aug 2026filed 1 Sep 2026 | ERNA Ernexa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,083 at $0.00 | filing |
| 21 Jun 2026filed 23 Jun 2026 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $6,2872,386 at $2.64 | filing |
| 21 Jun 2026filed 23 Jun 2026 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $6,2992,386 at $2.64 | filing |
| 21 Mar 2026filed 24 Mar 2026 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $2,9552,318 at $1.28 | filing |
| 21 Mar 2026filed 24 Mar 2026 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $2,9672,318 at $1.28 | filing |
| 13 Jan 2026filed 15 Jan 2026 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $6,0744,865 at $1.25 | filing |
| 13 Jan 2026filed 15 Jan 2026 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code A | $62K50,000 at $1.25 | filing |
| 13 Jan 2026filed 15 Jan 2026 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $6,0814,865 at $1.25 | filing |
| 13 Jan 2026filed 15 Jan 2026 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code A | $63K50,000 at $1.25 | filing |
| 21 Dec 2025filed 23 Dec 2025 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $2,5301,961 at $1.29 | filing |
| 25 Oct 2025filed 28 Oct 2025 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $5,6434,180 at $1.35 | filing |
| 23 Sep 2025filed 25 Sep 2025 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $1,9001,284 at $1.48 | filing |
| 21 Sep 2025filed 22 Sep 2025 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $2,9351,970 at $1.49 | filing |
| 21 Jun 2025filed 24 Jun 2025 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $3,7552,347 at $1.60 | filing |
| 29 May 2025filed 30 May 2025 | RFL Rafael Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code X | —76,882 at $0.00 | filing |
| 29 May 2025filed 30 May 2025 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code X | $98K76,882 at $1.28 | filing |
| 21 Mar 2025filed 25 Mar 2025 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $4,5902,378 at $1.93 | filing |
News
No headline names them, or the companies they trade most, lately.